Literature DB >> 2452083

Identification and characterization of HIV-specific RNase H by monoclonal antibody.

J Hansen1, T Schulze, W Mellert, K Moelling.   

Abstract

Human immune deficiency virus (HIV) replicates by conversion of the RNA genome into the double-stranded DNA provirus. The reverse transcriptase is not the only enzymatic function crucial in DNA-provirus synthesis. A viral-coded RNase H activity which specifically degrades RNA in RNA-DNA hybrids has been shown to be essential as well. Here we demonstrate that the HIV-reverse transcriptase which consists of a two-polypeptide complex, p66 and p51, copurifies with an RNase H activity which exhibits properties of a processive exonuclease. Only the p66 molecule, not p51, is active as polymerase as evidenced by activated gel analysis. p66 exhibits RNase H activity when precipitated as immune complex by a monoclonal antibody raised against a bacterially expressed carboxy-terminal portion of p66. The monoclonal antibody which does not interfere with enzyme activity also precipitates a second population of molecules with RNase H activity which is of low mol. wt, p15. This RNase H appears therefore to be derived from the carboxy terminus of p66 during processing to the p51 polypeptide. It exhibits low template-binding ability and is of a non-processing mode of action which may be due to the absence of the reverse transcriptase domain. These results lend experimental support to the hypothesis that the RNase H gene maps at the carboxy terminus of the reverse transcriptase. Since both RNase H populations are virus-coded they may be essential for retrovirus replication in general and useful targets for chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452083      PMCID: PMC454263          DOI: 10.1002/j.1460-2075.1988.tb02805.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  22 in total

1.  Effect of viral RNase H on the avian sarcoma viral genome during early transcription in vitro.

Authors:  R Friedrich; K Moelling
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Isolation and characterization of a ribonuclease from human leukemic blood cells specific for ribonucleic acid of ribonucleic acid-deoxyribonucleic acid hybrid molecules.

Authors:  M G Sarngadharan; J P Leis; R C Gallo
Journal:  J Biol Chem       Date:  1975-01-25       Impact factor: 5.157

3.  Isolation and characterization of two types of ribonucleases H in Krebs II ascites cells.

Authors:  G Cathala; J Rech; J Huet; P Jeanteur
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

4.  Degradation of DNA RNA hybrids by ribonuclease H and DNA polymerases of cellular and viral origin.

Authors:  W Keller; R Crouch
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

5.  Association of viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids.

Authors:  K Mölling; D P Bolognesi; H Bauer; W Büsen; H W Plassmann; P Hausen
Journal:  Nat New Biol       Date:  1971-12-22

6.  Characterization of reverse transcriptase and RNase H from friend-murine leukemia virus.

Authors:  K Moelling
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

7.  Purification and characteristics of hybridase (ribonuclease H) from rat-liver cytosol.

Authors:  W Roewekamp; C E Sekeris
Journal:  Eur J Biochem       Date:  1974-04-01

8.  Further characterization of the Friend murine leukemia virus reverse transcriptase-RNase H complex.

Authors:  K Moelling
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

9.  Reverse transcriptase of RNA tumor viruses. V. In vitro proteolysis of reverse transcriptase from avian myeloblastosis virus and isolation of a polypeptide manifesting only RNase H activity.

Authors:  M H Lai; I M Verma
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

10.  Multiple RNase H activities in mammalian type C retravirus lysates.

Authors:  G F Gerard
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

View more
  60 in total

1.  Defects in Moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli RNase H.

Authors:  A Telesnitsky; S W Blain; S P Goff
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

2.  Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

Authors:  P L Boyer; A L Ferris; S H Hughes
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

3.  Regulation of the reverse transcriptase of human immunodeficiency virus type 1 by dNTPs.

Authors:  A B West; T M Roberts; R D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

4.  Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases.

Authors:  D D Loeb; C A Hutchison; M H Edgell; W G Farmerie; R Swanstrom
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  The p15 carboxyl-terminal proteolysis product of the human immunodeficiency virus type 1 reverse transcriptase p66 has DNA polymerase activity.

Authors:  P Hafkemeyer; E Ferrari; J Brecher; U Hübscher
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

6.  Enzyme activities in four different forms of human immunodeficiency virus 1 pol gene products.

Authors:  Y W Hu; C Y Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain.

Authors:  J S Smith; M J Roth
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Mutational analysis of the reverse transcriptase and ribonuclease H domains of the human foamy virus.

Authors:  D Kögel; M Aboud; R M Flügel
Journal:  Nucleic Acids Res       Date:  1995-07-25       Impact factor: 16.971

9.  Detection of an RNase H activity associated with hepadnaviruses.

Authors:  S M Oberhaus; J E Newbold
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Two highly antigenic sites in the human immunodeficiency virus type 1 reverse transcriptase.

Authors:  E Björling; C A Boucher; A Samuelsson; T F Wolfs; G Utter; E Norrby; F Chiodi
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.